Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap
Posted inClinical Updates Hematology-Oncology news

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap

This review explores the Global Lymphoma Registry Alliance’s roadmap for leveraging multinational real-world data collaborations to address lymphoma’s heterogeneity, optimize treatment strategies, and improve patient outcomes worldwide through data harmonization, multi-stakeholder collaboration, and innovative registry integration.
Association Between Menopausal Hormone Therapy and Alzheimer Disease Neuropathology: Insights from Large Cohort Studies
Posted inClinical Updates Neurology news OB/GYN & Women's Health

Association Between Menopausal Hormone Therapy and Alzheimer Disease Neuropathology: Insights from Large Cohort Studies

This review synthesizes recent evidence linking menopausal hormone therapy (MHT), particularly estrogen-only regimens, with decreased Alzheimer disease neuropathology and clinical dementia risk, highlighting biomarker correlations, clinical outcomes, and implications for therapeutic strategies in postmenopausal women.
Gut Microbiota-Derived Imidazole Propionate as a Predictor of Cardiometabolic Risk in Coronary Artery Disease: Evidence and Clinical Implications
Posted inCardiology Clinical Updates Gastroenterology news

Gut Microbiota-Derived Imidazole Propionate as a Predictor of Cardiometabolic Risk in Coronary Artery Disease: Evidence and Clinical Implications

Emerging evidence identifies circulating imidazole propionate, a gut microbiota-derived metabolite, as an independent predictor of major adverse cardiovascular events in patients with coronary artery disease, offering novel insights into personalized risk stratification and therapeutic targets.
Neurological Effects and Safety of Encapsulated Dexamethasone Sodium Phosphate in Pediatric Ataxia Telangiectasia: Insights from the NEAT Phase 3 Trial
Posted inClinical Updates Neurology news Pediatrics

Neurological Effects and Safety of Encapsulated Dexamethasone Sodium Phosphate in Pediatric Ataxia Telangiectasia: Insights from the NEAT Phase 3 Trial

The NEAT phase 3 trial evaluated erythrocyte-encapsulated dexamethasone sodium phosphate in children with ataxia telangiectasia aged 6–9 years, confirming safety but failing to demonstrate statistically significant neurological improvement over placebo.
Baseline Deep Capillary Plexus Ischemia as a Superior Predictor of Early Diabetic Retinopathy Complications Relative to Foveal Avascular Zone Enlargement
Posted inClinical Updates Diabetes & Endocrinology news Ophthalmology

Baseline Deep Capillary Plexus Ischemia as a Superior Predictor of Early Diabetic Retinopathy Complications Relative to Foveal Avascular Zone Enlargement

Deep capillary plexus ischemia quantified by geometric perfusion deficit predicts earlier and higher risk of diabetic retinopathy complications than foveal avascular zone enlargement, underscoring GPDd's clinical utility as a biomarker for personalized monitoring.
Intravenous Nicorandil in STEMI Patients Undergoing Primary PCI: Insights from the CLEAN Randomized Clinical Trial and Broader Evidence
Posted inCardiology Clinical Updates news

Intravenous Nicorandil in STEMI Patients Undergoing Primary PCI: Insights from the CLEAN Randomized Clinical Trial and Broader Evidence

The CLEAN trial shows intravenous nicorandil adjunctive to primary PCI does not significantly improve 12-month clinical outcomes in STEMI. Evidence suggests microvascular benefits but no consistent long-term mortality or infarct size reduction, challenging routine use in unselected patients.